Trade Summary

3 days ago, Gollob Jared, serving as Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 10,508 shares at $87.24 per share, for a total transaction value of $916,669.00. Following this transaction, Gollob Jared now holds 117,134 shares of KYMR.

This sale represents a 8.00% decrease in Gollob Jared's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.